MJNA (Medical Marijuana) ROCE %: -40.71% (As of Dec. 2017)


What is Medical Marijuana ROCE %?

Medical Marijuana MJNA +100.00% ROCE % is -40.71% as of Dec. 2017.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medical Marijuana's annualized ROCE % for the quarter that ended in Dec. 2017 was -40.71%.

Medical Marijuana  (OTCPK:MJNA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medical Marijuana ROCE % Related Terms

Medical Marijuana ROCE % Historical Data

* Premium members only.

The historical data trend for Medical Marijuana's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Marijuana ROCE % Chart

Medical Marijuana Annual Data
Trend Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
ROCE %
Get a 7-Day Free Trial -3.17 -3.39 -53.65 -5.06 -40.71

Medical Marijuana Semi-Annual Data
Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
ROCE % Get a 7-Day Free Trial -3.17 -3.39 -53.65 -5.06 -40.71

Medical Marijuana ROCE % Calculation

Medical Marijuana's annualized ROCE % for the fiscal year that ended in Dec. 2017 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2017 )  (A: Dec. 2016 )(A: Dec. 2017 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2017 )  (A: Dec. 2016 )(A: Dec. 2017 )
=-135.18/( ( (393.553 - 2.193) + (274.838 - 2.119) )/ 2 )
=-135.18/( (391.36+272.719)/ 2 )
=-135.18/332.0395
=-40.71 %

Medical Marijuana's ROCE % of for the quarter that ended in Dec. 2017 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2017 )  (Q: Dec. 2016 )(Q: Dec. 2017 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2017 )  (Q: Dec. 2016 )(Q: Dec. 2017 )
=-135.18/( ( (393.553 - 2.193) + (274.838 - 2.119) )/ 2 )
=-135.18/( ( 391.36 + 272.719 )/ 2 )
=-135.18/332.0395
=-40.71 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2017) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -40.71% mean?
Medical Marijuana (MJNA) has a ROCE % of -40.71% as of Dec. 2017.
Is Medical Marijuana's ROCE % too high?
Medical Marijuana's current ROCE % is -40.71%.
How does Medical Marijuana's ROCE % compare to UPC and ERBB?
Medical Marijuana's ROCE % of -40.71% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Marijuana's current ROCE % is -40.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Marijuana stock overvalued right now?
Medical Marijuana (MJNA) has a current ROCE % of -40.71%. The current ROCE % is -40.71%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Medical Marijuana (MJNA), the current ROCE % is -40.71% as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Marijuana Business Description

Address 2384 La Mirada Drive, Vista, CA, USA, 92081
Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others. The company operates through Retail and Wholesale division; Direct Sales division; and Manufacturing and Production Division.